ICD-10 Code C92.61 | Acute myeloid leukemia with 11q23-abnormality in remission Symptoms, Diagnosis, Billing

Acute myeloid leukemia (AML) with 11q23-abnormality in remission is a hematological malignancy characterized by the proliferation of myeloid blasts with a specific chromosomal abnormality. This condition is clinically significant as it indicates a specific subtype of AML that may respond differently to treatment. The ICD-10 Code C92.61 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate care and resource allocation.

What is ICD-10 Code C92.61 for Acute myeloid leukemia with 11q23-abnormality in remission?

ICD-10 Code C92.61 represents Acute myeloid leukemia with 11q23-abnormality in remission, indicating that the patient has achieved remission from this specific subtype of AML. This code should be used in clinical documentation and billing when a patient has a confirmed diagnosis of this condition and is currently in remission, allowing for accurate tracking of treatment outcomes and resource utilization.

ICD-10 Code C92.61 – Clinical Definition and Explanation of Acute myeloid leukemia with 11q23-abnormality in remission

Acute myeloid leukemia with 11q23-abnormality is a subtype of AML associated with specific genetic mutations that can influence treatment response and prognosis. The condition requires prompt medical attention due to its aggressive nature and potential complications. Understanding its clinical features is essential for effective management.

Key Clinical Features:

• Presence of myeloid blasts in the bone marrow and peripheral blood.
• Specific chromosomal abnormality at 11q23, often associated with poor prognosis.
• Symptoms may include fatigue, fever, and bleeding tendencies.
• Requires regular monitoring for relapse and treatment response.

ICD-10 Code C92.61 for Acute myeloid leukemia with 11q23-abnormality in remission – SOAP Notes & Clinical Use

ICD-10 Code C92.61 is utilized in SOAP notes to document the patient's remission status and guide treatment decisions. It plays a crucial role in capturing the patient's clinical history, ongoing assessments, and therapeutic interventions, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code C92.61 for Acute myeloid leukemia with 11q23-abnormality in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C92.61 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission in acute myeloid leukemia. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C92.61 – Acute myeloid leukemia with 11q23-abnormality in remission

Management of Acute myeloid leukemia with 11q23-abnormality in remission focuses on maintaining remission and preventing relapse. Treatment strategies may include targeted therapies and supportive care.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Regular blood transfusions to manage anemia.
• Growth factor support to enhance blood cell production.
• Monitoring for signs of relapse and managing complications.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Education on hygiene and avoiding exposure to infections.

How to Document Symptoms of Acute myeloid leukemia with 11q23-abnormality in remission (ICD-10 C92.61) in SOAP Notes

Subjective:

• Patient reports fatigue and occasional night sweats.
• History of easy bruising and bleeding.
• Denies fever or recent infections.

Objective:

• Complete blood count shows normal white blood cell count.
• Bone marrow biopsy confirms remission status.
• Vital signs stable with no signs of infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Acute myeloid leukemia with 11q23-abnormality in remission (ICD-10 Code C92.61)

Assessment:

• Diagnosis: Acute myeloid leukemia with 11q23-abnormality in remission.
• Severity: Currently in remission, monitored for relapse.
• Triggers: Previous chemotherapy and genetic predisposition.

Plan:

• Continue monitoring blood counts and bone marrow status.
• Educate patient on signs of relapse and when to seek care.
• Schedule follow-up appointments every 3 months.

Treatment & Plan Section for ICD-10 Code C92.61 – Acute myeloid leukemia with 11q23-abnormality in remission

• Regular follow-up with hematology for monitoring.
• Consideration of maintenance therapy based on risk factors.
• Patient education on lifestyle modifications to support health.
• Psychosocial support services to address emotional well-being.

Using ICD-10 Code C92.61 for Acute myeloid leukemia with 11q23-abnormality in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in SOAP notes.
• Use C92.61 in billing to reflect the patient's current treatment phase.
• Document any complications or additional treatments to support claims.
• Align treatment plans with clinical guidelines for justified billing.

Related ICD-10 Codes Often Used with Acute myeloid leukemia with 11q23-abnormality in remission

• C92.60 – Acute myeloid leukemia with 11q23-abnormality, not in remission
• C92.62 – Acute myeloid leukemia with 11q23-abnormality, in relapse

ICD-10 Code C92.61 in Medical Billing and Insurance for Acute myeloid leukemia with 11q23-abnormality in remission

ICD-10 Code C92.61 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the use of C92.61.
• Ensure that the code is used in conjunction with appropriate CPT codes for services rendered.
• Maintain clear records of patient progress and response to treatment.

Common CPT Pairings: